mab317 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
93
Structured Review
R&D Systems
mab317
Mab317, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mab317/Human%2FPrimate+IL-17%2FIL-17A+Antibody/pmc10579190__ard___2023___224479supp001-52-41-57
Average 93 stars, based on 13 article reviews
Mab317, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mab317/Human%2FPrimate+IL-17%2FIL-17A+Antibody/pmc10579190__ard___2023___224479supp001-52-41-57
Average 93 stars, based on 13 article reviews
mab317 - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Ex Vivo:Article Title: New biologic (Ab-IPL-IL17TM) for IL-17-mediated diseases: Identification of the bioactive sequence (nIL-17TM) for IL-17A/F function Article Snippet: .. Ex vivo analysis In vivo neutralisation and immunogenicity assays For the neutralisation assay (21), CD-1 mice (n = 5 per group) were injected i.p. with 100 μg of IL17 neutralising antibodies (secukinumab [Creative Biolabs, London, UK], bimekizumab [Creative Biolabs, UK] , In Vivo:Article Title: New biologic (Ab-IPL-IL17TM) for IL-17-mediated diseases: Identification of the bioactive sequence (nIL-17TM) for IL-17A/F function Article Snippet: .. Ex vivo analysis In vivo neutralisation and immunogenicity assays For the neutralisation assay (21), CD-1 mice (n = 5 per group) were injected i.p. with 100 μg of IL17 neutralising antibodies (secukinumab [Creative Biolabs, London, UK], bimekizumab [Creative Biolabs, UK] , Immunopeptidomics:Article Title: New biologic (Ab-IPL-IL17TM) for IL-17-mediated diseases: Identification of the bioactive sequence (nIL-17TM) for IL-17A/F function Article Snippet: .. Ex vivo analysis In vivo neutralisation and immunogenicity assays For the neutralisation assay (21), CD-1 mice (n = 5 per group) were injected i.p. with 100 μg of IL17 neutralising antibodies (secukinumab [Creative Biolabs, London, UK], bimekizumab [Creative Biolabs, UK] , Injection:Article Title: New biologic (Ab-IPL-IL17TM) for IL-17-mediated diseases: Identification of the bioactive sequence (nIL-17TM) for IL-17A/F function Article Snippet: .. Ex vivo analysis In vivo neutralisation and immunogenicity assays For the neutralisation assay (21), CD-1 mice (n = 5 per group) were injected i.p. with 100 μg of IL17 neutralising antibodies (secukinumab [Creative Biolabs, London, UK], bimekizumab [Creative Biolabs, UK] , Recombinant:Article Title: Therapeutic compositions for treatment of ocular inflammatory disorders Article Snippet: The neutralizing or function-blocking antibody against IL-17 may be a reformulated or humanized derivative of or bind to the epitope of human IL-17 affinity purified polyclonal antibody (Catalog # AF-317-NA, R&D Systems), human IL-17 allophycocyanin monoclonal antibody (clone 41802)(Catalog # IC3171A, R&D Systems), human IL-17 biotinylated affinity purified polyclonal antibody (Catalog # BAF317, R&D Systems), human IL-17 monoclonal antibody (clone 41802)(Catalog # MAB3171, R&D Systems), human IL-17 monoclonal antibody (clone 41809)(Catalog # MAB317, R&D Systems), human IL-17 phycoerythrin monoclonal antibody (clone 41802)(Catalog # IC3171P, R&D Systems), mouse IL-17 affinity purified polyclonal antibody (Catalog # AF-421-NA, R&D Systems), mouse IL-17 biotinylated affinity purified polyclonal antibody (Catalog # BAF421, R&D Systems), mouse IL-17 monoclonal antibody (clone 50101)(Catalog # MAB721, R&D Systems), or mouse IL-17 monoclonal antibody (clone 50104)(Catalog # MAB421, R&D Systems). .. Preferably, the neutralizing or function-blocking antibody against IL-17 may be a reformulated or humanized derivative of or bind to the epitope of monoclonal anti-human IL-17 antibody, (Clone: 41809, Catalog # Derivative Assay:Article Title: IL-17A antibodies Article Snippet: .. The following antibodies were used: mAb1926, MORmAb7700, MORmAb7706, MORmAb7708, mAb7357 (a mouse anti-human IL-17A neutralizing antibody derived from hybridoma C1863), mAb2832 (a mouse/human chimeric anti-human IL-17A neutralizing antibody derived from hybridoma C1861), Article Title: Antibodies to IL-17A and uses thereof Article Snippet: .. TABLE 2 Examples of lead scFv potencies in HIS FLAG IL-17A binding IL-17RA Fc assay IC50 (nM) in Clone name HTRF ® assay TINA1 213 TINA7 118 TINA10 59 TINA11 156 Antibody 1 12 TINA21 36 TINA22 53 TINA48 57 TINA51 80 TINA55 79 TINA62 4 TINA107 25 1.4 Epitope Binding Lead scFv were tested in epitope competition assays for inhibition of HIS FLAG human IL-17A (in house HEK EBNA derived) binding anti-human IL-17 antibodies including parent Antibody 1, Inhibition:Article Title: Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models. Article Snippet: Objective.. The proinflammatory cytokine interleukin-17A (IL-17A) is produced primarily by the CD4 T cell subset called Th17 cells, which is involved in host defense, inflammation, and autoimmune disorders.. This study was undertaken to investigate the effect of a high-affinity RNA molecule, called an aptamer, against human IL-17A on IL-17A–induced signal transduction in vitro and its anti-autoimmune efficacy in vivo in 2 mouse models of inflammation. Article Title: Antibodies to IL-17A and uses thereof Article Snippet: .. TABLE 2 Examples of lead scFv potencies in HIS FLAG IL-17A binding IL-17RA Fc assay IC50 (nM) in Clone name HTRF ® assay TINA1 213 TINA7 118 TINA10 59 TINA11 156 Antibody 1 12 TINA21 36 TINA22 53 TINA48 57 TINA51 80 TINA55 79 TINA62 4 TINA107 25 1.4 Epitope Binding Lead scFv were tested in epitope competition assays for inhibition of HIS FLAG human IL-17A (in house HEK EBNA derived) binding anti-human IL-17 antibodies including parent Antibody 1, Concentration Assay:Article Title: Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models. Article Snippet: Objective.. The proinflammatory cytokine interleukin-17A (IL-17A) is produced primarily by the CD4 T cell subset called Th17 cells, which is involved in host defense, inflammation, and autoimmune disorders.. This study was undertaken to investigate the effect of a high-affinity RNA molecule, called an aptamer, against human IL-17A on IL-17A–induced signal transduction in vitro and its anti-autoimmune efficacy in vivo in 2 mouse models of inflammation. Binding Assay:Article Title: Antibodies to IL-17A and uses thereof Article Snippet: .. TABLE 2 Examples of lead scFv potencies in HIS FLAG IL-17A binding IL-17RA Fc assay IC50 (nM) in Clone name HTRF ® assay TINA1 213 TINA7 118 TINA10 59 TINA11 156 Antibody 1 12 TINA21 36 TINA22 53 TINA48 57 TINA51 80 TINA55 79 TINA62 4 TINA107 25 1.4 Epitope Binding Lead scFv were tested in epitope competition assays for inhibition of HIS FLAG human IL-17A (in house HEK EBNA derived) binding anti-human IL-17 antibodies including parent Antibody 1, HTRF Assay:Article Title: Antibodies to IL-17A and uses thereof Article Snippet: .. TABLE 2 Examples of lead scFv potencies in HIS FLAG IL-17A binding IL-17RA Fc assay IC50 (nM) in Clone name HTRF ® assay TINA1 213 TINA7 118 TINA10 59 TINA11 156 Antibody 1 12 TINA21 36 TINA22 53 TINA48 57 TINA51 80 TINA55 79 TINA62 4 TINA107 25 1.4 Epitope Binding Lead scFv were tested in epitope competition assays for inhibition of HIS FLAG human IL-17A (in house HEK EBNA derived) binding anti-human IL-17 antibodies including parent Antibody 1, |